HTA, France and dissatisfaction with the system - notes from DIA in Geneva
This article was originally published in SRA
Executive Summary
The European Commission official was adamant. While stakeholders in the health technology assessment debate need to test different ways of working together, it should be "taken for granted" that the HTA process will remain separate from the regulatory approval process.